Predictive Biomarkers of Treatment Response in Major Depressive Disorder
Major depressive disorder (MDD) is a highly prevalent, debilitating disorder with a high rate of treatment resistance. One strategy to improve treatment outcomes is to identify patient-specific, pre-intervention factors that can predict treatment success. Neurophysiological measures such as electroe...
Main Authors: | Louise A. Stolz, Jordan N. Kohn, Sydney E. Smith, Lindsay L. Benster, Lawrence G. Appelbaum |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-11-01
|
Series: | Brain Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-3425/13/11/1570 |
Similar Items
-
Resting and TMS-EEG markers of treatment response in major depressive disorder: A systematic review
by: Rebecca Strafella, et al.
Published: (2022-08-01) -
When to hold and when to fold: Early prediction of nonresponse to transcranial magnetic stimulation in major depressive disorder
by: Harold A. Sackeim, et al.
Published: (2024-03-01) -
Effects of transcranial magnetic stimulation on anhedonia in treatment resistant major depressive disorder
by: Andrew M. Fukuda, et al.
Published: (2021-09-01) -
Potential of antithrombin III as a biomarker of antidepressive effect in major depressive disorder
by: R. Song, et al.
Published: (2021-04-01) -
Effects of rTMS Intervention on Functional Neuroimaging Activities in Adolescents with Major Depressive Disorder Measured Using Resting-State fMRI
by: Fengmei Lu, et al.
Published: (2023-11-01)